Early-Stage Breast Cancer Characteristics and Treatment Options
An early-stage breast cancer diagnosis opens up many treatment options with high success rates. Even so, early-stage breast cancer has stages or categories that help determine appropriate treatment options. The size and location of the tumor and the pathology confirming that no lymph nodes are affected comprise the assignment of Stages 0, 1, or 2.
Stage 0 Breast Cancer Characteristics:
- Non-invasive
- Ductal Carcinoma in situ (DCIS)
- Confined to the milk ducts or lobules
- 20% of Breast Cancer diagnoses in the U.S.
- No symptoms, or a recent lump or nipple discharge
Treatment Options for Stage 0:
- Lumpectomy to target the removal of the tumor and nearby tissue
- Mastectomy to remove one or both breasts
- Radiation therapy
Stage 1 Breast Cancer Characteristics:
- Invasive breast tissue affected.
- Changes in breast shape or size or lump palpated
- No lymph node was involved, or some cancerous cells were found in the lymph node.
- Highly treatable with good outcomes
- The tumor is 2 cm (3/4 of an inch) or less across
- Cancer has spread to 1 to 3 axillary lymph node(s), or cancer is found in internal mammary lymph nodes near the breast bone.
Stage 1 Treatment Options:
- Surgery
- Radiation
Stage 2 Breast Cancer Characteristics:
- Invasive
- Stages 2A or 2B
- The tumor is more than 2 cm but not more than 5 cm (2 inches) across
- Cancer has spread to 4 to 9 lymph nodes under the arm, or cancer has enlarged the internal mammary lymph nodes
Stage 2 Treatment Options:
- Breast-conserving surgery, followed by radiation
- Mastectomy, or a mastectomy followed by radiation
- Chemotherapy before or after surgery
- Hormone therapy, targeted drug therapy, and immunotherapy
To determine your stage and treatment, here is a quick guide to the language you may need when discussing options with your doctor per the American Cancer Society’s synopsis of the American Joint Committee on Cancer (AJCC) TNM staging system effective January 2018.
Glossary:
(T) – The extent (size) of the tumor
(N) – The spread to nearby lymph nodes
(M) – The spread (metastasis) to distant sites
(ER) – Estrogen Receptor protein presence in the tumor
(PR) – Progesterone Receptor protein presence in the tumor
(HER2) – the extent cancer makes too much of a protein called HER2
(G) – Grade, or the extent that cancer cells look like normal cells
Send UsA Message
The Power of a United Breast Cancer Team: Your Leading Breast Cancer Allies
From diagnosis to treatment and follow-ups, Charleston Oncology, as a part of the Department of Bon Secours St. Francis’ leading multidisciplinary cancer care team, plays a vital role in guiding patients through their breast cancer journey.
Celebrating Strength and Hope: Join Us for the 6th Annual Pink Promenade
Celebrating Strength and Hope: Join Us for the 6th Annual Pink Promenade Mount Pleasant Towne Centre is thrilled to announce our 6th Annual Pink Promenade Breast Cancer Awareness Fundraiser, an event that embodies hope, strength, and resilience. Scheduled for...
Jenny’s Journey Reflects Our Mission
At Charleston Oncology, the mission of healing all people with compassion, faith and excellence resonates through the hallways and translates into every patient interaction.
Myra Walks in a Patient’s Shoes
In the busy corridors of Charleston Oncology on a triple-booked day of patients, a moment of pure human kindness unfolded, illustrating what it truly means to walk in a patient’s shoes.
March is National Colorectal Cancer Awareness Month
March is Colorectal Cancer Awareness Month. This month, Charleston Oncology recognizes the importance of spreading awareness surrounding the disease.
Empowering Health: Charleston Oncology Observes National Cancer Prevention Month
Empowering Health: Charleston Oncology Observes National Cancer Prevention Month Every year in the United States, nearly 1.9 million people (about twice the population of South Dakota) face the life-altering diagnosis of cancer, according to the National Institutes of...